# Thrombo-inflammation in Acute Neurovascular Diseases: Definition of New Therapeutic Targets (TARGETS)

> **NCT07354321** · — · NOT_YET_RECRUITING · sponsor: **François Delvoye** · enrollment: 499 (estimated)

## Conditions studied

- Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
- Ischemic Stroke of Large or Medium Vessels

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07354321
- **Lead sponsor:** François Delvoye
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2032-05
- **Final completion:** 2032-12
- **Target enrollment:** 499 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07354321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07354321, "Thrombo-inflammation in Acute Neurovascular Diseases: Definition of New Therapeutic Targets (TARGETS)". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT07354321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*